Found: 5
Select item for more details and to access through your institution.
25380 Cholecystokinin-B Receptor -Mediates Growth of Hepatocellular Carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
4119 Cholecystokinin (CCK) Receptor Antagonist Reverses Nonalcoholic Steatohepatitis (NASH) by Reducing Hepatic Macrophages and Inflammatory Cytokines.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL).
- Published in:
- Genes, 2023, v. 14, n. 12, p. 2182, doi. 10.3390/genes14122182
- By:
- Publication type:
- Article
Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4949, doi. 10.3390/cancers13194949
- By:
- Publication type:
- Article
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article